HIGHLIGHTS
- who: Kashaf Khalid et al. from the Clinical and Biomedical Research Center (CBRC), Foundation University have published the article: Mining to Develop Next-Generation Vaccine Design against Borrelia burgdorferi: The Cause of Lyme Borreliosis, in the Journal: Vaccines 2022, 10, 1239. of /2022/
- what: Through this research the authors explored the immunodominant proteins of B. burgdorferi and developed a novel and reliable vaccine design with great immunological predictability as well as low contamination and autoimmunity risks. The studies have shown that the designed next-generation vaccine stimulates desirable immune responses thus potentially providing a viable . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.